You make a valid point. Since the whole discussion on the patents began, I've seen a lot of credible sources say that not the patents, but the complexities of the production processes are the bottleneck for up-scaling the number of doses. Here's one of the more recent explanations; it's not like manufacturing more T-shirts, and production can't be handed over to facilities that aren't well prepared to make this vaccine. But even if that's the case, in my opinion everything should be done to get other production facilities up to speed to help with the production, and that's something I don't see happening. I could be wrong, of course, but so far this reeks like an instance of "profits-over-human lifes," which is business as usual unfortunately...
You are viewing a single comment's thread from:
There are pharmaceutical plants in india begging for permission to manufacture the J&J style vax.
https://www.theguardian.com/australia-news/2021/apr/30/india-wants-access-to-cheap-copies-of-covid-vaccines-so-why-is-australia-holding-out